Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

Conditions

• Chin Augmentation

Eligibility Criteria

Sex

ALL

Age

22 Years - N/A

Healthy Volunteers

Accepted

Interventions

• Restylane Lyft with Lidocaine — DEVICE
  Sterile gel of hyaluronic acid.

Study Details

The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.

Key Dates

First listed

May 5, 2026

Start date

Jun 3, 2026

Status verified

Aug 2026

Primary completion

Nov 1, 2027

Completion

Feb 28, 2028

Study Design

Enrollment

100 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Arms

• Experimental: Dermal Filler for Indication: Restylane Lyft with Lidocaine
  Participants will receive initial treatment with Restylane Lyft with Lidocaine in the chin region at Baseline with an optional touch-up treatment at 1 month after initial treatment and an optional retreatment 12 months after the last treatment.

Primary Outcome Measure

Number of Participants With Treatment-Emergent Adverse Events (TEAEs) Related to Device And/Or Injection Procedure After the Month 12 Optional Retreatment [ Time Frame: From Month 12 up to 3 months after optional retreatment (i.e. Month 15) ]

Central Contacts

• Clinical Project Manager
  817-961-5000
  [email protected]

Locations (8)

Find similar trials in Westport, CT